Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy

被引：0
|
作者：
Azad, Amee D. [1 ]
Chen, Evan M. [2 ]
Hinkle, John [1 ]
Rayess, Nadim [1 ]
Wu, David [3 ]
Eliott, Dean [4 ,5 ]
Mruthyunjaya, Prithvi [1 ]
Parikh, Ravi [4 ,5 ,6 ]
机构：
[1] Stanford Univ, Sch Med, Dept Ophthalmol, Byers Eye Inst, 2452 Watson Court, Palo Alto, CA 94304 USA
[2] Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT USA
[3] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA
[4] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA
[5] Massachusetts Eye & Ear, Retina Serv, Boston, MA USA
[6] Manhattan Retina & Eye Consultants, New York, NY USA
来源：
OPHTHALMOLOGY RETINA | 2021年 / 5卷 / 04期
关键词：
Anti-vascular endothelial growth factor; Diabetic macular edema; Panretinal photocoagulation; Proliferative diabetic retinopathy; RANIBIZUMAB;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：390 / 392
页数：4
相关论文
共 50 条
  • [31] Diabetic macular edema and proliferative diabetic retinopathy treated with anti-vascular endothelial growth factor under the reimbursement policy in Taiwan
    Hsieh, Ming-Chieh
    Cheng, Chieh-Yin
    Li, Kun-Hsien
    Chuang, Chih-Chun
    Wu, Jian-Sheng
    Lee, Sheng-Ta
    Lu, Wei-Yang
    Chiu, Shin-Lin
    Liu, Yu-Ling
    Chen, San-Ni
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] Anti-vascular endothelial growth factor (anti-VEGF) compared with laser photocoagulation for the treatment of retinopathy of prematurity type 1
    Gonzalez C, Raul
    Diaz C, Marcela
    Garreton C, Rodolfo
    MEDWAVE, 2022, 22 (01):
  • [33] Current perspectives on use of anti-vascular endothelial growth factor agents for retinal disorders
    Sengupta, Sabyasachi
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (02) : 209 - 210
  • [34] Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
    Ratra, Dhanashree
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (02) : 367 - 368
  • [35] Anti-vascular endothelial growth factor therapy in retinopathy of prematurity: An updated literature review
    Alzuabi, Asma K.
    Alshammari, Ola M.
    Almousa, Abdullah N.
    Abouammoh, Marwan A.
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2022, 36 (03) : 260 - 269
  • [36] Comment on: A Caveat About Financial Incentives for Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
    Gosala, Seshubabu
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 250 : 190 - 191
  • [37] Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema
    Yang, Jangmi
    Shin, Sang Jin
    Suh, Jae Kyung
    Tchoe, Hajin
    Cho, Songhee
    Kang, Min Joo
    Jee, Donghyun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (07): : 667 - 675
  • [38] ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION
    Bonnin, Sophie
    Dupas, Benedicte
    Lavia, Carlo
    Erginay, Ali
    Dhundass, Myriam
    Couturier, Aude
    Gaudric, Alain
    Tadayoni, Ramin
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (03): : 426 - 434
  • [39] Anti-vascular endothelial growth factor therapy for diabetic macular edema
    Boyer, David S.
    Hopkins, J. Jill
    Sorof, Jonathan
    Ehrlich, Jason S.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2013, 4 (06) : 151 - 169
  • [40] Use of anti-vascular endothelial growth factor in the management of pterygium
    Mak, Renata Kiri
    Chan, Tommy Chung Yan
    Marcet, Marcus M.
    Choy, Bonnie Nga Kwan
    Shum, Jennifer Wei Huen
    Shih, Kendrick Co
    Wong, Ian Yat Hin
    Ng, Alex Lap Ki
    ACTA OPHTHALMOLOGICA, 2017, 95 (01) : 20 - 27
12345